WORLD PEPTIDEFOUNDATION
← Master Registry

Published peptide research references

CJC-1295

Governed registry record

25 approved source records with original-source links. Source verification confirms the reference and its connection to this record; it does not certify every scientific conclusion or establish safety or efficacy.

Open the peptide evidence profile →

Approved source records

  1. A new era of doping? Use of peptide and peptide-analog drugs in recreational and professional sport and bodybuilding: a critical review.

    Coutinho LFD, DE Oliveira Neves LF, Camilo RP. · 2026

    DOI: 10.23736/S0022-4707.26.17773-1PMID: 41880199

  2. Analysis of growth hormone releasing hormone and its analogs in urine using nano liquid chromatography coupled with quadrupole/orbitrap mass spectrometry.

    Uçaktürk E, Nemutlu E. · 2026

    DOI: 10.1016/j.jpba.2025.117207PMID: 41138283

  3. Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians.

    Mayfield CK, Bolia IK, Feingold CL, Lin EH, Liu JN, Rick Hatch GF, Gamradt SC, Weber AE. · 2026

    DOI: 10.1177/03635465251357593PMID: 41476424

  4. Injectable Peptides in Sports Medicine: A Structured Narrative Review of Evidence, Safety, and Antidoping Implications.

    Villegas Meza AD, Nocek M, Mitchell BC, Lizarraga M, DeFoor MT, Ruzbarsky JJ, Huard J, Philippon MJ. · 2026

    DOI: 10.2106/JBJS.RVW.26.00027PMID: 42160466

  5. Peptide Supplements and Their Therapeutic Applications in Sports Medicine.

    Tewari K, Liu TP, Im C, Hamad C, Petrigliano F, Cheung EC, Kremen TJ Jr. · 2026

    DOI: 10.1177/03635465261464420PMID: 42578445

  6. Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance.

    Mendias CL, Awan TM. · 2026

    DOI: 10.1007/s40279-026-02437-0PMID: 41966639

  7. Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future Perspectives.

    Renke G, Chinellato L. · 2026

    DOI: 10.3390/ijms27093890PMID: 42123471

  8. Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions.

    Rahman OF, Lee SJ, Seeds WA. · 2026

    DOI: 10.5435/JAAOSGlobal-D-25-00236PMID: 41490200

  9. Chromatographic-mass spectrometric analysis of peptidic analytes (2-10 kDa) in doping control urine samples.

    Thomas A, Walpurgis K, Thevis M. · 2024

    DOI: 10.1002/jms.4996PMID: 38197510

  10. Cationic exchange SPE combined with triple quadrupole UHPLC-MS/MS for detection of GHRHs in urine samples.

    Cristea CD, Radu M, Toboc A, Stan C, David V. · 2023

    DOI: 10.1016/j.ab.2023.115336PMID: 37806509

  11. An antibody-free, ultrafiltration-based assay for the detection of growth hormone-releasing hormones in urine at low pg/mL concentrations using nanoLC-HRMS/MS.

    Coppieters G, Deventer K, Polet M, Van Eenoo P, Judák P. · 2022

    DOI: 10.1016/j.jpba.2022.114726PMID: 35298973

  12. Early detection of cannabinoids in biological samples based on their affinity interaction with the growth hormone secretagogue receptor.

    Danila GM, Puiu M, Zamfir LG, Bala C. · 2022

    DOI: 10.1016/j.talanta.2021.122905PMID: 34736642

  13. Probing for peptidic drugs (2-10 kDa) in doping control blood samples.

    Thomas A, Thilmany S, Hofmann A, Thevis M. · 2022

    DOI: 10.1002/ansa.202200027PMID: 38716080

  14. Advances in the detection of growth hormone releasing hormone synthetic analogs.

    Memdouh S, Gavrilović I, Ng K, Cowan D, Abbate V. · 2021

    DOI: 10.1002/dta.3183PMID: 34665524

  15. Comparison of magnetic bead surface functionalities for the immunopurification of growth hormone-releasing hormones prior to liquid chromatography-high resolution mass spectrometry.

    Pont L, Alechaga É, Terrero A, Monfort N, Ventura R. · 2020

    DOI: 10.1016/j.chroma.2020.461548PMID: 32971474

  16. A method for confirming CJC-1295 abuse in equine plasma samples by LC-MS/MS.

    Timms M, Ganio K, Steel R. · 2019

    DOI: 10.1002/dta.2599PMID: 30938069

  17. An immuno polymerase chain reaction screen for the detection of CJC-1295 and other growth-hormone-releasing hormone analogs in equine plasma.

    Timms M, Ganio K, Forbes G, Bailey S, Steel R. · 2019

    DOI: 10.1002/dta.2554PMID: 30489688

  18. Netnography of Female Use of the Synthetic Growth Hormone CJC-1295: Pulses and Potions.

    Van Hout MC, Hearne E. · 2016

    DOI: 10.3109/10826084.2015.1082595PMID: 26771670

  19. Qualitative identification of growth hormone-releasing hormones in human plasma by means of immunoaffinity purification and LC-HRMS/MS.

    Knoop A, Thomas A, Fichant E, Delahaut P, Schänzer W, Thevis M. · 2016

    DOI: 10.1007/s00216-016-9377-3PMID: 26879649

  20. The study of doping market: How to produce intelligence from Internet forums.

    Pineau T, Schopfer A, Grossrieder L, Broséus J, Esseiva P, Rossy Q. · 2016

    DOI: 10.1016/j.forsciint.2016.09.017PMID: 27710891

  21. Expanded test method for peptides >2 kDa employing immunoaffinity purification and LC-HRMS/MS.

    Thomas A, Walpurgis K, Tretzel L, Brinkkötter P, Fichant E, Delahaut P, Schänzer W, Thevis M. · 2015

    DOI: 10.1002/dta.1868PMID: 26382721

  22. Activation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in serum protein profile changes in normal adult subjects.

    Sackmann-Sala L, Ding J, Frohman LA, Kopchick JJ. · 2009

    DOI: 10.1016/j.ghir.2009.03.001PMID: 19386527

  23. Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse.

    Alba M, Fintini D, Sagazio A, Lawrence B, Castaigne JP, Frohman LA, Salvatori R. · 2006

    DOI: 10.1152/ajpendo.00201.2006PMID: 16822960

  24. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults.

    Teichman SL, Neale A, Lawrence B, Gagnon C, Castaigne JP, Frohman LA. · 2006

    DOI: 10.1210/jc.2005-1536PMID: 16352683

  25. Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog.

    Ionescu M, Frohman LA. · 2006

    DOI: 10.1210/jc.2006-1702PMID: 17018654